U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with S

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
138023 Q2 2022 SACCHARIN SODIUM ORAL TABLET 84mg Correction
138024 Q3 2022 SACCHARIN SODIUM ORAL TABLET 43mg Correction
138025 Q2 2022 SODIUM BENZOATE BUCCAL FILM, SOLUBLE 3mg Correction
138026 Q3 2022 SODIUM BENZOATE BUCCAL FILM, SOLUBLE 3mg Correction
138027 Q3 2022 SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE INTRAVENOUS INJECTABLE, LIPOSOMAL 129mg Correction
138028 Q2 2022 SODIUM N-(MPEG 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE INTRAVENOUS INJECTION 0.01 %w/v Correction
138029 Q3 2022 SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE INTRAVENOUS INJECTION 1mg Correction
138030 Q2 2022 SODIUM PHOSPHATE, MONOBASIC INTRAVENOUS INJECTION, SOLUTION 0.35 %w/v Correction
138031 Q3 2022 SODIUM PHOSPHATE, MONOBASIC INTRAVENOUS INJECTION, SOLUTION 27mg Correction
138032 Q2 2022 SORBITAN MONOOLEATE TOPICAL GEL 1.00 %w/w Correction
138033 Q3 2022 SORBITAN MONOOLEATE TOPICAL GEL 6mg Correction
138034 Q2 2022 SORBITOL ORAL CAPSULE, LIQUID FILLED 75mg Correction
138035 Q3 2022 SORBITOL ORAL CAPSULE, LIQUID FILLED 51mg Correction
138036 Q2 2022 STARCH 1500, PREGELATINIZED BUCCAL TABLET 16.60 mg Correction
138037 Q3 2022 STARCH, CORN BUCCAL TABLET 9mg Correction
138038 Q2 2022 STARCH 1500, PREGELATINIZED ORAL CAPSULE 5785mg Correction
138039 Q3 2022 STARCH, CORN ORAL CAPSULE 5785mg Correction
138040 Q2 2022 STARCH 1500, PREGELATINIZED ORAL CAPSULE, COATED, EXTENDED RELEASE 19mg Correction
138041 Q3 2022 STARCH, CORN ORAL CAPSULE, COATED, EXTENDED RELEASE 19mg Correction
138042 Q2 2022 STARCH 1500, PREGELATINIZED ORAL CAPSULE, DELAYED RELEASE 216mg Correction
138043 Q3 2022 STARCH, CORN ORAL CAPSULE, DELAYED RELEASE 216mg Correction
138044 Q2 2022 STARCH 1500, PREGELATINIZED ORAL CAPSULE, EXTENDED RELEASE 194mg Correction
138045 Q3 2022 STARCH, CORN ORAL CAPSULE, EXTENDED RELEASE 194mg Correction
138046 Q2 2022 STARCH 1500, PREGELATINIZED ORAL CONCENTRATE NA Correction
138047 Q3 2022 STARCH, CORN ORAL CONCENTRATE NA Correction
138048 Q2 2022 STARCH 1500, PREGELATINIZED ORAL DROPS NA Correction
138049 Q3 2022 STARCH, CORN ORAL DROPS NA Correction
138050 Q2 2022 STARCH 1500, PREGELATINIZED ORAL LIQUID, EXTENDED RELEASE 113mg Correction
138051 Q3 2022 STARCH, CORN ORAL LIQUID, EXTENDED RELEASE 113mg Correction
138052 Q2 2022 STARCH 1500, PREGELATINIZED ORAL PASTILLE NA Correction
138053 Q3 2022 STARCH, CORN ORAL PASTILLE NA Correction
138054 Q2 2022 STARCH 1500, PREGELATINIZED ORAL POWDER, FOR SUSPENSION 34mg Correction
138055 Q3 2022 STARCH, CORN ORAL POWDER, FOR SUSPENSION 34mg Correction
138056 Q2 2022 STARCH 1500, PREGELATINIZED ORAL SUSPENSION 72.50 mg/ 5.00 ml Correction
138057 Q3 2022 STARCH, CORN ORAL SUSPENSION 900mg Correction
138058 Q2 2022 STARCH 1500, PREGELATINIZED ORAL SUSPENSION/ DROPS NA Correction
138059 Q3 2022 STARCH, CORN ORAL SUSPENSION/ DROPS 90mg Correction
138060 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET 1116mg Correction
138061 Q3 2022 STARCH, CORN ORAL TABLET 1116mg Correction
138062 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, CHEWABLE 180mg Correction
138063 Q3 2022 STARCH, CORN ORAL TABLET, CHEWABLE 180mg Correction
138064 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, COATED 285.00 mg Correction
138065 Q3 2022 STARCH, CORN ORAL TABLET, COATED 256mg Correction
138066 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, DELAYED RELEASE 240mg Correction
138067 Q3 2022 STARCH, CORN ORAL TABLET, DELAYED RELEASE 240mg Correction
138068 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, EXTENDED RELEASE 184mg Correction
138069 Q3 2022 STARCH, CORN ORAL TABLET, EXTENDED RELEASE 184mg Correction
138070 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, FILM COATED 696mg Correction
138071 Q3 2022 STARCH, CORN ORAL TABLET, FILM COATED 696mg Correction
138072 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, FILM COATED, EXTENDED RELEASE 74.30 mg Correction
138073 Q3 2022 STARCH, CORN ORAL TABLET, FILM COATED, EXTENDED RELEASE 149mg Correction
138074 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, ORALLY DISINTEGRATING 100mg Correction
138075 Q3 2022 STARCH, CORN ORAL TABLET, ORALLY DISINTEGRATING 100mg Correction
138076 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE 10mg Correction
138077 Q3 2022 STARCH, CORN ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE 10mg Correction
138078 Q2 2022 STARCH 1500, PREGELATINIZED SUBLINGUAL TABLET 409mg Correction
138079 Q3 2022 STARCH, CORN SUBLINGUAL TABLET 409mg Correction
138080 Q2 2022 STARCH 1500, PREGELATINIZED VAGINAL INSERT 210.00 mg Correction
138081 Q3 2022 STARCH, CORN VAGINAL INSERT 4mg Correction
138082 Q2 2022 STARCH 1500, PREGELATINIZED VAGINAL TABLET 210.00 mg Correction
138083 Q3 2022 STARCH, CORN VAGINAL TABLET 300mg Correction
138084 Q2 2022 STARCH 1500, PREGELATINIZED VAGINAL TABLET, FILM COATED 8.00 mg Correction
138085 Q3 2022 STARCH, CORN VAGINAL TABLET, FILM COATED 8mg Correction
138143 Q3 2022 SESAME OIL ORAL TABLET, COATED NA Deletion
138144 Q3 2022 SILICA DIMETHYL SILYLATE TRANSDERMAL SYSTEM 38.59 mg Deletion
138145 Q3 2022 SODIUM LAURYL SULFATE ORAL TABLET, MULTILAYER, EXTENDED RELEASE 42.50 mg 43mg Deletion
138146 Q3 2022 SODIUM PHOSPHATE, DIBASIC TOPICAL SOLUTION 0.50 %w/v Deletion
138147 Q3 2022 SORBITAN MONOLAURATE NASAL AEROSOL, SPRAY 22.90 mg Deletion
138148 Q3 2022 STEARIC ACID ORAL TABLET, COATED PARTICLES 5.00 mg 40mg Deletion
138409 Q2 2022 SACCHARIN SODIUM ORAL GRANULE, FOR SOLUTION 5.50 mg MDE Replacement
138410 Q3 2022 SACCHARIN SODIUM ORAL GRANULE, FOR SOLUTION 3mg MDE Replacement
138411 Q2 2022 SACCHARIN SODIUM ORAL PASTE 0.08 mg/ 1.00 ml MDE Replacement
138412 Q3 2022 SACCHARIN SODIUM ORAL PASTE 3mg MDE Replacement
138413 Q2 2022 SCOTCHPAK 1022 TRANSDERMAL FILM, EXTENDED RELEASE 904.92 mg MDE Replacement
138414 Q3 2022 SCOTCHPAK 1022 TRANSDERMAL FILM, EXTENDED RELEASE 2335mg MDE Replacement
138415 Q2 2022 SILICON DIOXIDE ORAL CAPSULE, EXTENDED RELEASE 106.00 mg MDE Replacement
138416 Q3 2022 SILICON DIOXIDE ORAL CAPSULE, EXTENDED RELEASE 168mg MDE Replacement
138417 Q2 2022 SILICON DIOXIDE ORAL GRANULE, FOR SOLUTION 1.80 mg MDE Replacement
138418 Q3 2022 SILICON DIOXIDE ORAL GRANULE, FOR SOLUTION 3mg MDE Replacement
138419 Q2 2022 SILICON DIOXIDE ORAL POWDER 100.00 mg MDE Replacement
138420 Q3 2022 SILICON DIOXIDE ORAL POWDER 602mg MDE Replacement
138421 Q2 2022 SIMETHICONE ORAL POWDER, FOR SOLUTION 0.40 mg/ 5.00 ml MDE Replacement
138422 Q3 2022 SIMETHICONE ORAL POWDER, FOR SOLUTION 8mg MDE Replacement
138423 Q2 2022 SIMETHICONE EMULSION ORAL PASTE 1.80 mg/ 1.00 ml MDE Replacement
138424 Q3 2022 SIMETHICONE EMULSION ORAL PASTE 54mg MDE Replacement
138425 Q2 2022 SIMETHICONE EMULSION ORAL SOLUTION 0.08 mg/ 5.00 ml MDE Replacement
138426 Q3 2022 SIMETHICONE EMULSION ORAL SOLUTION 2mg MDE Replacement
138427 Q2 2022 SIMETHICONE EMULSION ORAL SUSPENSION 350 mg MDE Replacement
138428 Q3 2022 SIMETHICONE EMULSION ORAL SUSPENSION 13mg MDE Replacement
138429 Q2 2022 SODIUM BENZOATE ORAL PASTE 0.92 mg/ 1.00 ml MDE Replacement
138430 Q3 2022 SODIUM BENZOATE ORAL PASTE 28mg MDE Replacement
138431 Q2 2022 SODIUM BENZOATE ORAL POWDER, FOR SOLUTION 98.00 mg MDE Replacement
138432 Q3 2022 SODIUM BENZOATE ORAL POWDER, FOR SOLUTION 98mg MDE Replacement
138433 Q2 2022 SODIUM BENZOATE ORAL SOLUTION 330.00 mg MDE Replacement
138434 Q3 2022 SODIUM BENZOATE ORAL SOLUTION 660mg MDE Replacement
138435 Q2 2022 SODIUM BICARBONATE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 573.50 mg MDE Replacement
138436 Q3 2022 SODIUM BICARBONATE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 3059mg MDE Replacement
138437 Q2 2022 SODIUM BISULFITE ORAL SUSPENSION 2.00 mg/ 5.00 ml MDE Replacement
138438 Q3 2022 SODIUM BISULFITE ORAL SUSPENSION 5mg MDE Replacement
138439 Q2 2022 SODIUM CHLORIDE INTRAVENOUS SOLUTION 9.00 mg MDE Replacement
138440 Q3 2022 SODIUM CHLORIDE INTRAVENOUS SOLUTION 90mg MDE Replacement
138441 Q2 2022 SODIUM CHLORIDE SUBMUCOSAL INJECTION 0.16 %w/v MDE Replacement
138442 Q3 2022 SODIUM CHLORIDE SUBMUCOSAL INJECTION 17mg MDE Replacement
138443 Q2 2022 SODIUM HYDROXIDE ORAL TABLET, FILM COATED 1.50 mg MDE Replacement
138444 Q3 2022 SODIUM HYDROXIDE ORAL TABLET, FILM COATED 8mg MDE Replacement
138445 Q2 2022 SODIUM LAURYL SULFATE ORAL TABLET, FOR SUSPENSION 48.00 mg MDE Replacement
138446 Q3 2022 SODIUM LAURYL SULFATE ORAL TABLET, FOR SUSPENSION 264mg MDE Replacement
138447 Q2 2022 SODIUM METABISULFITE SUBMUCOSAL INJECTION 0.05 %w/v MDE Replacement
138448 Q3 2022 SODIUM METABISULFITE SUBMUCOSAL INJECTION 5mg MDE Replacement
138449 Q2 2022 SODIUM N-(MPEG 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE INTRAVENOUS INJECTABLE, LIPOSOMAL 0.32 %w/v MDE Replacement
138450 Q3 2022 SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE INTRAVENOUS INJECTABLE, LIPOSOMAL 129mg MDE Replacement
138451 Q2 2022 SODIUM N-(MPEG 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE INTRAVENOUS INJECTION 0.01 %w/v MDE Replacement
138452 Q3 2022 SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE INTRAVENOUS INJECTION 1mg MDE Replacement
138453 Q2 2022 SODIUM PHOSPHATE, DIBASIC INTRAVENOUS SOLUTION 0.01 %w/v MDE Replacement
138454 Q3 2022 SODIUM PHOSPHATE, DIBASIC INTRAVENOUS SOLUTION 52mg MDE Replacement
138455 Q2 2022 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE INTRAVENOUS INJECTION 0.24 %w/v MDE Replacement
138456 Q3 2022 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE INTRAVENOUS INJECTION 55mg MDE Replacement
138457 Q2 2022 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 0.04 %w/v MDE Replacement
138458 Q3 2022 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 3mg MDE Replacement
138459 Q2 2022 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE NASAL SPRAY 3.00 mg/ 1.00 ml MDE Replacement
138460 Q3 2022 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE NASAL SPRAY 12mg MDE Replacement
138461 Q2 2022 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 0.04 %w/v MDE Replacement
138462 Q3 2022 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 3mg MDE Replacement
138463 Q2 2022 SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE NASAL SPRAY 6.64 mg/ 1.00 ml MDE Replacement
138464 Q3 2022 SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE NASAL SPRAY 7mg MDE Replacement
138465 Q2 2022 SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE OPHTHALMIC SOLUTION/ DROPS 0.55 %w/v MDE Replacement
138466 Q3 2022 SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE OPHTHALMIC SOLUTION/ DROPS 43mg MDE Replacement
138467 Q2 2022 SODIUM PHOSPHATE, MONOBASIC INTRAVENOUS INJECTION, SOLUTION 0.35 %w/v MDE Replacement
138468 Q3 2022 SODIUM PHOSPHATE, MONOBASIC INTRAVENOUS INJECTION, SOLUTION 27mg MDE Replacement
138469 Q2 2022 SODIUM PHOSPHATE, MONOBASIC ORAL TABLET 1.38 mg MDE Replacement
138470 Q3 2022 SODIUM PHOSPHATE, MONOBASIC ORAL TABLET 1mg MDE Replacement
138471 Q2 2022 SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE ORAL SUSPENSION 2225 mg MDE Replacement
138472 Q3 2022 SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE ORAL SUSPENSION 80mg MDE Replacement
138473 Q2 2022 SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 0.64 mg MDE Replacement
138474 Q3 2022 SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2mg MDE Replacement
138475 Q2 2022 SODIUM STARCH GLYCOLATE TYPE A ORAL TABLET, FOR SUSPENSION 30.00 mg MDE Replacement
138476 Q3 2022 SODIUM STARCH GLYCOLATE TYPE A ORAL TABLET, FOR SUSPENSION 165mg MDE Replacement
138477 Q2 2022 SODIUM STARCH GLYCOLATE TYPE A ORAL TABLET, ORALLY DISINTEGRATING 71.43 mg MDE Replacement
138478 Q3 2022 SODIUM STARCH GLYCOLATE TYPE A ORAL TABLET, ORALLY DISINTEGRATING 29mg MDE Replacement
138479 Q2 2022 SODIUM STEARYL FUMARATE ORAL CAPSULE 15.00 mg MDE Replacement
138480 Q3 2022 SODIUM STEARYL FUMARATE ORAL CAPSULE 180mg MDE Replacement
138481 Q2 2022 SODIUM STEARYL FUMARATE ORAL CAPSULE, EXTENDED RELEASE 7.00 mg MDE Replacement
138482 Q3 2022 SODIUM STEARYL FUMARATE ORAL CAPSULE, EXTENDED RELEASE 11mg MDE Replacement
138483 Q2 2022 SODIUM STEARYL FUMARATE ORAL GRANULE, FOR SOLUTION 18.20 mg MDE Replacement
138484 Q2 2022 SODIUM STEARYL FUMARATE ORAL GRANULE, FOR SOLUTION 18.20 mg MDE Replacement
138485 Q3 2022 SODIUM STEARYL FUMARATE ORAL GRANULE, FOR SOLUTION 1mg MDE Replacement
138486 Q3 2022 SODIUM STEARYL FUMARATE ORAL GRANULE, FOR SOLUTION 9mg MDE Replacement
138487 Q2 2022 SODIUM THIOSULFATE INTRAVENOUS INJECTION 4.00 mg MDE Replacement
138488 Q3 2022 SODIUM THIOSULFATE INTRAVENOUS INJECTION 18mg MDE Replacement
138489 Q2 2022 SORBITAN MONOOLEATE TOPICAL GEL 1.00 %w/w MDE Replacement
138490 Q3 2022 SORBITAN MONOOLEATE TOPICAL GEL 6mg MDE Replacement
138491 Q2 2022 SORBITOL INTRAVENOUS INJECTION, SOLUTION 30.00 %w/v MDE Replacement
138492 Q3 2022 SORBITOL INTRAVENOUS INJECTION, SOLUTION 3000mg MDE Replacement
138493 Q2 2022 SORBITOL NASAL SPRAY 6.17 mg/ 1.00 ml MDE Replacement
138494 Q3 2022 SORBITOL NASAL SPRAY 49mg MDE Replacement
138495 Q2 2022 SORBITOL SOLUTION ORAL SUSPENSION 35430 mg MDE Replacement
138496 Q3 2022 SORBITOL SOLUTION ORAL SUSPENSION 1275mg MDE Replacement
138497 Q2 2022 SQUALANE TOPICAL CREAM, AUGMENTED 6.00 %w/w MDE Replacement
138498 Q3 2022 SQUALANE TOPICAL CREAM, AUGMENTED 120mg MDE Replacement
138499 Q2 2022 STARCH 1500, PREGELATINIZED ORAL SUSPENSION 72.50 mg/ 5.00 ml MDE Replacement
138500 Q3 2022 STARCH, CORN ORAL SUSPENSION 900mg MDE Replacement
138501 Q2 2022 STARCH 1500, PREGELATINIZED ORAL SUSPENSION/ DROPS NA MDE Replacement
138502 Q3 2022 STARCH, CORN ORAL SUSPENSION/ DROPS 90mg MDE Replacement
138503 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, COATED 285.00 mg MDE Replacement
138504 Q3 2022 STARCH, CORN ORAL TABLET, COATED 256mg MDE Replacement
138505 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, FILM COATED, EXTENDED RELEASE 74.30 mg MDE Replacement
138506 Q3 2022 STARCH, CORN ORAL TABLET, FILM COATED, EXTENDED RELEASE 149mg MDE Replacement
138507 Q2 2022 STARCH 1500, PREGELATINIZED VAGINAL TABLET 210.00 mg MDE Replacement
138508 Q3 2022 STARCH, CORN VAGINAL TABLET 300mg MDE Replacement
138509 Q2 2022 STARCH 1500, PREGELATINIZED VAGINAL TABLET, FILM COATED 8.00 mg MDE Replacement
138510 Q3 2022 STARCH, CORN VAGINAL TABLET, FILM COATED 8mg MDE Replacement
138511 Q2 2022 STEARIC ACID ORAL CAPSULE, EXTENDED RELEASE 25.50 mg MDE Replacement
138512 Q3 2022 STEARIC ACID ORAL CAPSULE, EXTENDED RELEASE 64mg MDE Replacement
138513 Q2 2022 STEAROYL POLYOXYLGLYCERIDES ORAL CAPSULE 480.00 mg MDE Replacement
138514 Q3 2022 STEAROYL POLYOXYLGLYCERIDES ORAL CAPSULE 960mg MDE Replacement
138515 Q2 2022 STRAWBERRY ORAL SUSPENSION 0.70 mg/ 1.00 ml MDE Replacement
138516 Q3 2022 STRAWBERRY ORAL SUSPENSION 21mg MDE Replacement
138517 Q2 2022 SUCRALOSE NASAL SPRAY, METERED 1.50 mg/ 1.00 ml MDE Replacement
138518 Q3 2022 SUCRALOSE NASAL SPRAY, METERED 12mg MDE Replacement
138519 Q2 2022 SUCROSE ORAL CAPSULE, COATED, EXTENDED RELEASE 86.01 mg MDE Replacement
138520 Q3 2022 SUCROSE ORAL CAPSULE, COATED, EXTENDED RELEASE 86mg MDE Replacement
138521 Q2 2022 SUCROSE SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 4.25 %w/v MDE Replacement
138522 Q3 2022 SUCROSE SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 308mg MDE Replacement
138523 Q2 2022 SUCROSE STEARATE ORAL TABLET, EXTENDED RELEASE 44.56 mg MDE Replacement
138524 Q3 2022 SUCROSE STEARATE ORAL TABLET, EXTENDED RELEASE 57mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: July 1, 2022
Database Last Updated: July 18, 2022

Back to Top